Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

1.

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.

Nicholls SJ, Kastelein JJ, Schwartz GG, Bash D, Rosenson RS, Cavender MA, Brennan DM, Koenig W, Jukema JW, Nambi V, Wright RS, Menon V, Lincoff AM, Nissen SE; VISTA-16 Investigators.

JAMA. 2014 Jan 15;311(3):252-62. doi: 10.1001/jama.2013.282836.

PMID:
24247616
[PubMed - indexed for MEDLINE]
2.

Statin pretreatment and presentation patterns in patients with coronary artery disease.

Ndrepepa G, Fusaro M, King L, Cassese S, Tada T, Schömig A, Kastrati A.

Cardiol J. 2013;20(1):52-8. doi: 10.5603/CJ.2013.0009.

PMID:
23558811
[PubMed - indexed for MEDLINE]
Free Article
3.

Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] study).

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I; TRUTH Investigators.

Am J Cardiol. 2013 Apr 1;111(7):923-9. doi: 10.1016/j.amjcard.2012.12.008. Epub 2013 Jan 18.

PMID:
23337838
[PubMed - indexed for MEDLINE]
4.

[Early administrations of statins after acute coronary syndrome].

Linde JJ, Jensen GB.

Ugeskr Laeger. 2012 Jun 25;174(26):1801-3. Danish.

PMID:
22735112
[PubMed - indexed for MEDLINE]
5.

Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.

Miyauchi K, Daida H, Morimoto T, Hiro T, Kimura T, Nakagawa Y, Yamagishi M, Ozaki Y, Kadota K, Kimura K, Hirayama A, Kimura K, Hasegawa Y, Uchiyama S, Matsuzaki M; JAPAN-ACS Investigators.

Circ J. 2012;76(4):825-32.

PMID:
22451449
[PubMed - indexed for MEDLINE]
Free Article
6.

Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.

Looi KL, Chow KL, Looi JL, Lee M, Halliday S, White H, Ellis C.

N Z Med J. 2011 Sep 23;124(1343):18-27.

PMID:
21964009
[PubMed - indexed for MEDLINE]
7.

[Coronary microvascular dysfunction. An update].

Lamendola P, Di Franco A, Tarzia P, Milo M, Laurito M, Lanza GA.

Recenti Prog Med. 2011 Sep;102(9):329-37. doi: 10.1701/948.10373. Italian.

PMID:
21947187
[PubMed - indexed for MEDLINE]
8.

Statins for acute coronary syndrome.

Vale N, Nordmann AJ, Schwartz GG, de Lemos J, Colivicchi F, den Hartog F, Ostadal P, Macin SM, Liem AH, Mills E, Bhatnagar N, Bucher HC, Briel M.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD006870. doi: 10.1002/14651858.CD006870.pub2. Review.

PMID:
21678362
[PubMed - indexed for MEDLINE]
9.

Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22.

Truong QA, Murphy SA, McCabe CH, Armani A, Cannon CP; TIMI Study Group.

Circ Cardiovasc Qual Outcomes. 2011 May;4(3):328-36. doi: 10.1161/CIRCOUTCOMES.110.957720. Epub 2011 Apr 12.

PMID:
21487089
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The effect of early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome.

He XZ, Zhou SH, Wan XH, Wang HY, Zhong QH, Xue JF.

Clin Cardiol. 2011 Jan;34(1):59-63. doi: 10.1002/clc.20818. Epub 2010 Dec 10. Retraction in: Clin Cardiol. 2013 Aug;36(8):494.

PMID:
21259280
[PubMed - indexed for MEDLINE]
11.

[Evaluation of hospitalization period and five-year follow-up of patients admitted with acute coronary syndrome following coronary artery bypass graft surgery].

Can LH, Kayıkçıoğlu M, Yavuzgil O, Kültürsay H, Soydan I.

Turk Kardiyol Dern Ars. 2010 Sep;38(6):387-92. Turkish.

PMID:
21200116
[PubMed - indexed for MEDLINE]
12.

Effects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injury.

Yu XL, Zhang HJ, Ren SD, Geng J, Wu TT, Chen WQ, Ji XP, Zhong L, Ge ZM.

Coron Artery Dis. 2011 Mar;22(1):87-91. doi: 10.1097/MCA.0b013e328341baee.

PMID:
21169815
[PubMed - indexed for MEDLINE]
13.

What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial.

Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP; PROVE IT-TIMI 22 Trial Investigators.

Circulation. 2010 Nov 23;122(21):2142-51. doi: 10.1161/CIRCULATIONAHA.109.905687. Epub 2010 Nov 8.

PMID:
21060068
[PubMed - indexed for MEDLINE]
Free Article
14.

Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22.

Bonaca MP, Morrow DA, Braunwald E, Cannon CP, Jiang S, Breher S, Sabatine MS, Kempf T, Wallentin L, Wollert KC.

Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):203-10. doi: 10.1161/ATVBAHA.110.213512. Epub 2010 Oct 21.

PMID:
20966402
[PubMed - indexed for MEDLINE]
Free Article
15.

Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients.

Rosenson RS, Hislop C, Elliott M, Stasiv Y, Goulder M, Waters D.

J Am Coll Cardiol. 2010 Sep 28;56(14):1079-88. doi: 10.1016/j.jacc.2010.06.015. Erratum in: J Am Coll Cardiol. 2011 Mar 29;57(13):1501.

PMID:
20863951
[PubMed - indexed for MEDLINE]
Free Article
16.
17.

Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial).

Acharjee S, Qin J, Murphy SA, McCabe C, Cannon CP.

Am J Cardiol. 2010 Mar 1;105(5):619-23. doi: 10.1016/j.amjcard.2009.10.042.

PMID:
20185006
[PubMed - indexed for MEDLINE]
18.

Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design.

Flather MD, Booth J, Babalis D, Bueno H, Steg PG, Opolski G, Ottani F, Machecourt J, Bardaji A, Bojestig M, Brady AR, Lindahl B.

Trials. 2010 Jan 14;11:5. doi: 10.1186/1745-6215-11-5.

PMID:
20074348
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Acute coronary syndromes: clinical characteristics, management, and outcomes at the American University of Beirut Medical Center, 2002-2005.

Abdallah M, Karrowni W, Shamseddeen W, Itani S, Kobeissi L, Ghazzal Z, Alam S, Dakik HA.

Clin Cardiol. 2010 Jan;33(1):E6-E13. doi: 10.1002/clc.20636.

PMID:
20014175
[PubMed - indexed for MEDLINE]
20.

Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.

Zhao SP, Peng DQ, Yu BL, Huo Y; CHILLAS investigators.

Am Heart J. 2009 Oct;158(4):509-512.e1. doi: 10.1016/j.ahj.2009.07.030.

PMID:
19781407
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk